newsfilter
← Latest News
GlobeNewswire·

Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – – Appointments of Dan Baker,